research indic abax new vetscan rapid test like
strong show compani launch product later month
sinc believ success abax like new product
come direct expens believ prudent adjust
forecast reflect concern
remind tradit own segment rapid test
market gener estim million annual revenu
product howev abax product longer shelf life
room-temperatur storag versu refriger eas use
attract price point versu moreov
research indic new clinic studi identifi superior
identifi instanc anaplasmosi identifi infect
produc three serotyp canin ehrlichiosi earli clinic
evid suggest abax offer effect possibl accur
research indic tri mitig threat new competit
abax contact indic compani current attempt
lock custom long-term purchas contract rais
price current user addit recogn snap analyz
also help insul compani competit threat
believ abax well-equip compet effect steal share
rapid test market new vetscan reduc
assay intern growth rate
new intern growth rate basi
point prior forecast reduc ep forecast
forecast ep
longer shelf life room-temperatur storag attract price point
higher accuraci believ posit abax take share
rapid test market expens veterinari distribut
contact indic alreadi sit consider order product
expect constant flow product begin calendar abax
invest money time ad autom contract manufactur
partner abl meet grow demand although current
attempt lock custom long-term contract believ ultim
clinic characterist attract price point make product real
threat idxx high margin product line reiter neutral
rate share
import pleas read disclosur disclaim page report
total debt total asset
inc northcoast researchannu incom statement market sale market interest incom tax share consolid extra incom extra average share ep extra growth growth compani report northcoast research estim disclosur
